Tips

四月美迪西將主辦3場線上直播，同時參與5場行業(yè)會議，期待與各位業(yè)內(nèi)同仁交流分享藥物研發(fā)新趨勢。

第6屆BIONNOVA生物醫(yī)藥創(chuàng)新者論壇暨展覽會

2025年4月9-10日，第6屆BIONNOVA生物醫(yī)藥創(chuàng)新者論壇暨展覽會誠邀新老朋友再次相約上海張江科學(xué)會堂，與10000+生物醫(yī)藥全產(chǎn)業(yè)鏈創(chuàng)新實踐者同筑新程!

美迪西生物技術(shù)藥物分析部負責(zé)人章登吉博士將受邀出席，并在4月9日“抗體偶聯(lián)藥物前沿探索”論壇分享：從CRO視角看ADC/XDC類藥物研發(fā)趨勢及對臨床前研究的分析挑戰(zhàn)。

美迪西團隊將在T02號展位，等待您的蒞臨交流！

20th Annual Drug Discovery Chemistry

Optimizing Small Molecules for Tomorrow’s Therapeutics
Medicilon Booth #510

Medicilon offers comprehensive drug discovery services, encompassing medicinal and synthetic chemistry, along with biology expertise. We empower pharmaceutical, biotech, and academic researchers to accelerate small molecule drug candidate discovery and optimization. Leveraging FTE and FFS models, we provide integrated chemistry research services and employ cutting-edge technologies like AI, PROTAC, and ADC technology to efficiently advance projects, control costs, and ensure superior quality.

AACR 2025

Medicilon is excited to exhibit at the AACR Annual Meeting, a premier forum for cancer research advances. Meet Dr. Qingcong Lin, President of Medicilon USA Corp., Dr. Lilly Xu, CTO of Medicilon, and Dr. Baohong Cao, VP of Pharmacology. 

Dr. Weizhong Zhang will present a Medicilon poster on "Developing PDX-Derived Organoid Models for Efficacy Evaluation of Anticancer Therapies" on Sunday, April 27, from 2:00 PM-5:00 PM, Poster #26, Section 2.

Join Medicilon at booth #3740 to discuss your research needs. 

Nordic Precision Medicine Forum 2025

Nordic Precision Medicine Forum brings four tracks under one roof. The multi topic forum is dedicated to advancing the diagnosis, prognosis and treatment of disease across the Nordics. Bringing together those leading the move towards more personalised approaches, Nordic Precision Medicine Forum is considered the meeting for the region. Benefiting from insight on Nordic and international initiatives, attendees of Nordic Precision Medicine Forum will have the opportunity to come together, ask questions, problem solve and network with key opinion leaders in Precision Medicine and the fields of oncology and pathology. 

Medicilon is excited to attend and exhibit at the conference. Dr. Paul G.J. van Stralen, VP Strategic Collaborations EMEA at Medicilon, will be available at the conference. We look forward to greeting you in Stockholm! 

18th Drug Discovery Strategic Summit

18th Drug Discovery Strategic Summit (DDSS) is designed to ignite business innovation and foster progress. Grounded in deep industry expertise and shaped by client insights. Where Innovation Meets Opportunity: Exclusive Summits for Drug Discovery Leaders. 

Medicilon will exhibit at the 18th DDSS. Medicilon's drug discovery services integrate chemistry and biology, offering custom synthesis, compound library construction, SAR compound synthesis and screening, and compound structure and biological activity optimization. Our medicinal chemistry team utilizes computational chemistry to enhance compound design and incorporates advanced technologies to efficiently deliver high-quality results while controlling costs.

marketing@medicilon.com.cn
媒體與會務(wù)請聯(lián)系
美迪西市場部微信或郵箱